SU5416 plus hypoxia but not selective VEGFR2 inhibition with cabozantinib plus hypoxia induces pulmonary hypertension in rats: potential role of BMPR2 signaling is a research paper published in Pulmonary Circulation (2021). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: HL 102946
Foundation for the National Institutes of Health
Grant: Grant HL 102946
NHLBI NIH HHS
Grant: R44 HL102946
NHLBI NIH HHS
Grant: R43 HL102946
National Institutes of Health
Grant: 5R44HL102946-03
An inhaled PDGF receptor inhibitor for the treatment of pulmonary arterial hyper
FWCI
0.39
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals